These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Right Ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients. Nippoldt TB; Edwards WD; Holmes DR; Reeder GS; Hartzler GO; Smith HC Mayo Clin Proc; 1982 Jul; 57(7):407-18. PubMed ID: 6211578 [TBL] [Abstract][Full Text] [Related]
7. Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failure undergoing endomyocardial biopsy. Mueller KA; Tavlaki E; Schneider M; Jorbenadze R; Geisler T; Kandolf R; Gawaz M; Mueller II; Zuern CS J Card Fail; 2013 Oct; 19(10):678-84. PubMed ID: 24125106 [TBL] [Abstract][Full Text] [Related]
8. Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults. Parson SJ; Russell SD; Bennett MK; Dunn JM; Gilotra NA; Rao S; Harrington C; Freitag TB; Foster MC; Halushka MK Cardiovasc Pathol; 2012; 21(4):317-23. PubMed ID: 22153555 [TBL] [Abstract][Full Text] [Related]
9. [Contribution of myocardial biopsy and immunohistochemistry to the prognostic evaluation of cardiac amyloidosis]. Van de Walle JP; Fourcade L; Panagides D; Harle JR; Pellissier JF; Touze JE; Bory M Arch Mal Coeur Vaiss; 1994 Feb; 87(2):235-9. PubMed ID: 7802531 [TBL] [Abstract][Full Text] [Related]
10. Yield of endomyocardial biopsy in patients with biventricular failure. Comparison of patients with normal vs reduced left ventricular ejection fraction. French WJ; Siegel RJ; Cohen AH; Laks MM Chest; 1986 Aug; 90(2):181-4. PubMed ID: 3731889 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. Rahman JE; Helou EF; Gelzer-Bell R; Thompson RE; Kuo C; Rodriguez ER; Hare JM; Baughman KL; Kasper EK J Am Coll Cardiol; 2004 Feb; 43(3):410-5. PubMed ID: 15013123 [TBL] [Abstract][Full Text] [Related]